back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-10-01 13:23 Tx date 2024-09-26 |
$HUGE
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,750
+3,000 vol $5.25 each |
38,000 | |
| Filed 2024-10-01 13:21 Tx date 2024-09-26 |
$HUGE
Quantum BioPharma Ltd. |
Kotra, Lakshmi
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$39,375
+7,500 vol $5.25 each |
7,500 | |
| Filed 2024-10-01 13:17 Tx date 2024-09-26 |
$HUGE
Quantum BioPharma Ltd. |
Coyle, Nathan Patrick
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,750
+3,000 vol $5.25 each |
||
| Filed 2024-09-30 19:33 Tx date 2024-09-06 |
$HUGE
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Lucky Square Holdings Inc. (Indirect Ownership)
|
Options
50 - Grant of options
|
+12,500 vol |
12,500 | |
| Filed 2024-09-30 19:31 Tx date 2023-06-29 |
$HUGE
Quantum BioPharma Ltd. |
Hoskins, Eric William
4 - Director of Issuer
Holder: Lucky Square Holdings Inc. (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-09-16 09:15 Tx date 2024-09-13 |
$HUGE
Quantum BioPharma Ltd. |
Saeed, Zeeshan
4 - Director of Issuer, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Holder: Xorax Family Trust (Indirect Ownership)
|
Multiple Voting Shares Class A
11 - Acquisition or disposition carried out privately
|
$18.00
+3 vol $6.00 each |
6 | |
| Filed 2024-09-16 09:11 Tx date 2024-09-13 |
$HUGE
Quantum BioPharma Ltd. |
Durkacz, Anthony John
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Fortius Research and Trading Corp. (Indirect Ownership)
|
Multiple Voting Shares Class A
11 - Acquisition or disposition carried out privately
|
$18.00
+3 vol $6.00 each |
6 | |
| Filed 2024-09-09 13:52 Tx date 2018-06-12 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$270,000
+3,000,000 vol $0.09 each |
||
| Filed 2024-09-09 13:52 Tx date 2018-09-14 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,200,000
+2,000,000 vol $0.60 each |
||
| Filed 2024-09-09 13:52 Tx date 2019-10-16 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-4,975,125 vol |
||
| Filed 2024-09-09 13:52 Tx date 2019-12-20 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+50,000 vol |
||
| Filed 2024-09-09 13:51 Tx date 2020-02-23 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-24,875 vol |
||
| Filed 2024-09-09 13:51 Tx date 2020-03-24 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+39,801 vol |
||
| Filed 2024-09-09 13:51 Tx date 2020-04-14 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+15,000 vol |
||
| Filed 2024-09-09 13:51 Tx date 2021-06-01 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+600,000 vol |
||
| Filed 2024-09-09 13:51 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-381,500
-50,000 vol $7.63 each |
||
| Filed 2024-09-09 13:50 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-153,631.86
-39,801 vol $3.86 each |
||
| Filed 2024-09-09 13:50 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-71,250
-15,000 vol $4.75 each |
||
| Filed 2024-09-09 13:49 Tx date 2022-04-06 |
$HUGE
FSD Pharma Inc. |
Carroll, Donal
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-1,350,000
-600,000 vol $2.25 each |
||
| Filed 2024-09-09 13:45 Tx date 2018-05-24 |
$HUGE
FSD Pharma Inc. |
Xorax Family Trust
3 - 10% Security Holder of Issuer
Direct Ownership
|
Multiple Voting Shares Class A
00 - Opening Balance-Initial SEDI Report
|